Evidence map›Paper›PMID 42104490›Full record

ArticleJournal of cheminformatics2026

Scaffold-based evaluation metrics for fair comparison of molecular generators.

Valeriia Fil, Remco L Van Den Broek, Martin Šícho, Ivan Čmelo, M Isabel Agea, Willem Jespers, Gerard J P Van Westen, Daniel Svozil

Erratum issuedAbstract read
In one paragraph

Article in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Valeriia Fil *Department of Informatics and Chemistry & CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Faculty of Chemical Technology, University of Chemistry and Technology Prague, Technická 5, CZ-166 28, Prague, Czech Republic.
Remco L Van Den Broek *Division of Medicinal Chemistry, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Martin ŠíchoDepartment of Informatics and Chemistry & CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Faculty of Chemical Technology, University of Chemistry and Technology Prague, Technická 5, CZ-166 28, Prague, Czech Republic.
Ivan ČmeloDepartment of Informatics and Chemistry & CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Faculty of Chemical Technology, University of Chemistry and Technology Prague, Technická 5, CZ-166 28, Prague, Czech Republic.
M Isabel AgeaDepartment of Informatics and Chemistry & CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Faculty of Chemical Technology, University of Chemistry and Technology Prague, Technická 5, CZ-166 28, Prague, Czech Republic.
Willem JespersDivision of Medicinal Chemistry, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Gerard J P Van WestenDivision of Medicinal Chemistry, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands. gerard@gjpvanwesten.nl.
Daniel SvozilDepartment of Informatics and Chemistry & CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Faculty of Chemical Technology, University of Chemistry and Technology Prague, Technická 5, CZ-166 28, Prague, Czech Republic. svozild@vscht.cz.

Funding

Czech Science Foundation 22-17367OMinistry of Education, Youth and Sports of the Czech Republic LM2023052Oncode Accelerator, a Dutch National Growth Fund NGFOP2201
6 · The paper itself

Abstract

Molecular generators enable the exploration of chemical space to identify novel compounds with desirable properties. However, assessing their performance remains challenging due to the structural diversity and volume of the generated molecules. Commonly used evaluation metrics, focusing on chemical validity and novelty, do not fully align with the primary goal of molecular generation: the discovery of new biologically active compounds. To address this limitation, we introduce scaffold-based metrics that enable a fair comparison by evaluating a generator's ability to recover biologically relevant scaffolds absent from the input set. We applied the scaffold Recovery Score (RS), SEt scaffold Diversity (SED), and Absolute SEt scaffold Recall (ASER) metrics to compare several molecular generators, including Molpher, DrugEx, REINVENT, and Graph-based genetic algorithm. The proposed scaffold-based metrics provide a realistic framework for evaluating and optimizing molecular generators for their practical use in drug discovery scenarios, particularly in the design of focused virtual chemical libraries. The metrics are available as open-source in a GitHub repository at https://github.com/filvaleriia/scaffold-based-metrics .

Indexed as

BenchmarksDe novo drug designMolecular generationScaffold-based metricsScaffold-hopping

Identifiers

PMID42104490
PMCPMC13330364

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.